Role of the RNA-binding protein HuR in apoptosis and apoptosome function

Apoptosome: An Up-and-coming Therapeutical Tool

Volumn 9789048134151, Issue , 2010, Pages 203-220

  Kuwano, Yuki ^a   Gallouzi, Imed Eddine ^b   Gorospe, Myriam ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

mRNA stability; Ribonucleoprotein complex; Translational control post transcriptional gene regulation

Indexed keywords

EID: 84896721874     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-90-481-3415-1_10     Document Type: Chapter

References (104)

1. Abdelmohsen, K., Kuwano, Y., Kim, H. H., and Gorospe, M. (2008). Post-transcriptional gene regulation by RNA-binding proteins during oxidative stress: implications for cellular senescence. Biol Chem 389, 243-255.
2. Abdelmohsen, K., Pullmann, R. Jr., Lal, A., Kim, H. H., Galban, S., Yang, X., Blethrow, J. D., Walker, M., Shubert, J., Gillespie, D. A., Furneaux, H., and Gorospe, M. (2007a). Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol Cell 25, 543-557.
3. Abdelmohsen, K., Lal, A., Kim, H. H., and Gorospe, M. (2007b). Posttranscriptional orchestration of an anti-apoptotic program by HuR. Cell Cycle 6, 1288-1292.
4. Atasoy, U., Watson, J., Patel, D., and Keene, J. D. (1998). ELAV protein HuA (HuR) can redistribute between nucleus and cytoplasm and is upregulated during serum stimulation and T cell activation. J Cell Sci 111, 3145-3156.
5. Bensaad, K. and Vousden, K. H. (2007) p53: new roles in metabolism. Trends Cell Biol 17, 286-291.
6. Blander, G. and Guarente, L. (2004). The Sir2 family of protein deacetylases. Annu Rev Biochem 73, 417-435.
7. Brennan, C. M., Gallouzi, I. E., and Steitz, J. A. (2000). Protein ligands to HuR modulate its interaction with target mRNAs in vivo. J Cell Biol 151, 1-14.
8. Brennan, C. M. and Steitz, J. A. (2001). HuR and mRNA stability. Cell Mol Life Sci 58, 266-277.
9. Brooks, C. L. and Gu, W. (2003). Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 15, 164-171.
10. Brooks, C. L. and Gu, W. (2006). p53 ubiquitination: Mdm2 and beyond. Mol Cell 21, 307-315.
11. Brown, G. C. and Borutaite, V. (2008). Regulation of apoptosis by the redox state of cytochrome c. Biochim Biophys Acta 1777, 877-881.
12. Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F., Greer, P. L., Lin, Y., Tran, H., Ross, S. E., Mostoslavsky, R., Cohen, H. Y., et al. (2004). Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 2011-2015.
13. Bunz, F., Hwang, P. M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K. W., and Vogelstein, B. (1999). Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J Clin Invest 104, 263-269.
14. Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., and Vogelstein, B. (1998). Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282, 1497-501.
15. Campisi, J. (2002). Cancer and aging: yin, yang, and p53. Sci Aging Knowledge Environ 2002(1), pe1.
16. Cherry, J., Karschner, V., Jones, H., Pekala, P. H. (2006). HuR, an RNA-binding protein, involved in the control of cellular differentiation. In Vivo 20, 17-23.
17. Chu, I. M., Hengst, L., and Slingerland, J. M. (2008). The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer 8, 253-267.
18. Cohen, H. Y., Lavu, S., Bitterman, K. J., Hekking, B., Imahiyerobo, T. A., Miller, C., Frye, R., Ploegh, H., Kessler, B. M., and Sinclair, D. A. (2004). Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol. Cell 13, 627-638.
19. Degterev, A., Boyce, M., and Yuan, J. (2003). A decade of caspases. Oncogene 22, 8543-8567.
20. Dixon, D. A., Tolley, N. D., King, P. H., Nabors, L. B., McIntyre, T. M., Zimmerman, G. A., and Prescott, S. M. (2001). Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Invest 108, 1657-1665.
21. Doller, A., Akool, el-S., Huwiler, A., Müller, R., Radeke, H. H., Pfeilschifter, J., and Eberhardt, W. (2008). Posttranslational modification of the AU-rich element binding protein HuR by protein kinase Cdelta elicits angiotensin II-induced stabilization and nuclear export of cyclooxygenase 2 mRNA. Mol Cell Biol 28, 2608-2625.
22. Doller, A., Huwiler, A., Müller, R., Radeke, H. H., Pfeilschifter, J., and Eberhardt, W. (2007). Protein kinase C alpha-dependent phosphorylation of the mRNA-stabilizing factor HuR: implications for posttranscriptional regulation of cyclooxygenase-2. Mol Biol Cell 18, 2137-2148.
23. Dosil, M., Alvarez-Fernandez, L., and Gomez-Marquez, J. (1993). Differentiation-linked expression of prothymosin a gene in human myeloid leukemic cells. Exp Cell Res 204, 94-101.
24. Eilers, M., Schirm, S., and Bishop, J. M. (1991). The MYC protein activates transcription of the a-prothymosin gene. EMBO J 10, 133-141
25. Fabbri, M., Croce, C. M., and Calin, G. A. (2008). MicroRNAs. Cancer J 14, 1-6.
26. Fan, X. C. and Steitz, J. A. (1998). HNS, a nuclear-cytoplasmic shuttling sequence in HuR. Proc Natl Acad Sci USA 95, 15293-15298.
27. Fan, Z., Beresford, P. J., Oh, D. Y., Zhang, D., and Lieberman, J. (2003). Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell, 112, 659-672.
28. Figueroa, A., Cuadrado, A., Fan, J., Atasoy, U., Muscat, G. E., Muoz-Canoves, P., Gorospe, M., and Muoz, A. (2003) Role of HuR in skeletal myogenesis through coordinate regulation of muscle differentiation genes. Mol Cell Biol 23(14):4991-5004.
29. Frye, R. A. (2000). Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys Res Commun 273, 793-798.
30. Fulda, S., and Debatin, K. M. (2006). Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25, 4798-4811
31. Galbán, S., Kuwano, Y., Pullmann, R. Jr., Martindale, J. L., Kim, H. H., Lal, A., Abdelmohsen, K., Yang, X., Dang, Y., Liu, J. O., Lewis, S. M., Holcik, M., and Gorospe, M. (2008). RNA-binding proteins HuR and PTB promote the translation of hypoxia-inducible factor 1alpha. Mol Cell Biol 28, 93-107.
32. Gallouzi, I. E., Brennan, C. M., and Steitz, J. A. (2001). Protein ligands mediate the CRM1-dependent export of HuR in response to heat shock. RNA 7, 1348-1361.
33. Gallouzi, I. E. and Steitz, J. A. (2001). Delineation of mRNA export pathways by the use of cell-permeable peptides. Science. 294, 1895-901.
34. Gorospe, M. (2003). HuR in the mammalian genotoxic response: post-transcriptional multitasking. Cell Cycle 2, 412-414.
35. Gorospe, M., Cirielli, C., Wang, X., Seth, P., Capogrossi, M. C., and Holbrook, N. J. (1997). p21 (Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene. 14, 929-935.
36. Gorospe, M. and Holbrook, N. J. (1996). Role of p21 in prostaglandin A2-mediated cellular arrest and death. Cancer Res 56, 475-479.
37. Gorospe, M., Wang, X., Guyton, K. Z., and Holbrook, N. J. (1996). Protective role of p21 (Waf1/Cip1) against prostaglandin A2-mediated apoptosis of human colorectal carcinoma cells. Mol Cell Biol 16, 6654-6660.
38. Gorospe, M., Wang, X., and Holbrook, N. J. (1999). Functional role of p21 during the cellular response to stress. Gene Expr 7, 377-385.
39. Green, D. R. (2005). Apoptotic pathways: ten minutes to dead. Cell 121, 671-674.
40. Guo, X. and Hartley, R. S. (2006). HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells. Cancer Res 66, 7948-7956.
41. Güttinger, S., Mühlhäusser, P., Koller-Eichhorn, R., Brennecke, J., and Kutay, U. (2004) Transportin2 functions as importin and mediates nuclear import of HuR. Proc Natl Acad Sci USA 101, 2918-2923.
42. Hengartner, M. O. (2000). The biochemistry of apoptosis. Nature 407, 770-776.
43. Hannappel, E. and Huff, T. (2003). The thymosins, Prothymosin alpha, Parathymosin, and beta-thymosins: structure and function. Vitam Horm 66, 257-96. Review.
44. Higashino, F., Aoyagi, M., Takahashi, A., Ishino, M., Taoka, M., Isobe, T., Kobayashi, M., Totsuka, Y., Kohgo, T., and Shindoh, M. (2005). Adenovirus E4orf6 targets pp32/LANP to control the fate of ARE-containing mRNAs by perturbing the CRM1-dependent mechanism. J Cell Biol 170, 15-20.
45. Hill, M. M., Adrain, C., Duriez, P. J., Creagh, E. M., and Martin, S. J. (2004). Analysis of the composition, assembly kinetics and activity of native Apaf-1 apoptosomes. EMBO J 23, 2134-2145.
46. Jares, P., Colomer, D., and Campo, E. (2007). Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer 7, 750-762.
47. Jiang, X., Kim, H. E., Shu, H., Zhao, Y., Zhang, H., Kofron, J., Donnelly, J., Burns, D., Ng, S. C., Rosenberg, S., and Wang, X. (2003). Distinctive roles of PHAP proteins and prothymosin-a in a death regulatory pathway. Science 299, 223-226.
48. Kanaoka, S., Takai, T., Yoshida, K. (2007). Cyclooxygenase-2 and tumor biology. Adv Clin Chem 43, 59-78.
49. Katayose, Y., Kim, M., Rakkar, A. N., Li, Z., Cowan, K. H., and Seth, P. (1997). Promoting apop-tosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res 57, 5441-5445.
50. Kaufman, R. J. (2002). Orchestrating the unfolded protein response in health and disease. J Clin Invest 110, 1389-1398.
51. Kaufmann, S. H. and Hengartner, M. O. (2001). Programmed cell death: alive and well in the new millennium. Trends Cell Biol 11, 526-534
52. Kawai, T., Lal, A., Yang, X., Galban, S., Mazan-Mamczarz, K., and Gorospe, M. (2006). Translational control of cytochrome c by RNA-binding proteins TIA-1 and HuR. Mol Cell Biol 26, 3295-3307.
53. Keene, J. D. (2007). RNA regulons: coordination of post-transcriptional events. Nat Rev Genet 8, 533-543.
54. Kim, H. H., Abdelmohsen, K., Lal, A., Pullmann, R. Jr., Yang, X., Galban, S., Srikantan, S., Martindale, J. L., Blethrow, J., Shokat, K. M., and Gorospe, M. (2008a). Nuclear HuR accumulation through phosphorylation by Cdk1. Genes Dev 22, 1804-1815.
55. Kim, H. H., Yang, X., Kuwano, Y., and Gorospe, M. (2008b). Modification at HuR (S242) alters HuR localization and proliferative influence. Cell Cycle 7 [Epub ahead of print]PMID: 18948743
56. Kim, H. H. and Gorospe M. (2008). Phosphorylated HuR shuttles in cycles. Cell Cycle 7, 3124-3126.
57. Kullmann, M., Gopfert, U., Siewe, B., and Hengst, L. (2002). ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5'UTR. Genes Dev 16, 3087-3099.
58. Kurumbail, R. G., Kiefer, J. R., and Marnett, L. J. (2001). Cyclooxygenase enzymes: catalysis and inhibition. Curr Opin Struct Biol 11, 752-760.
59. Kuwano, Y., Kim, H. H., Abdelmohsen, K., Pullmann, R. Jr., Martindale, J. L., Yang, X., and Gorospe, M. (2008). MKP-1 mRNA stabilization and translational control by RNA-binding proteins HuR and NF90. Mol Cell Biol 28, 4562-75.
60. Kuwano, Y. and Gorospe, M. (2008). Protecting the stress response, guarding the MKP-1 mRNA. Cell Cycle 7, 2640-2642.
61. Lafon, I., Carballès, F., Brewer, G., Poiret, M., and Morello, D. (1998). Developmental expression of AUF1 and HuR, two c-myc mRNA binding proteins. Oncogene 16(26), 3413-21.
62. Lal, A., Mazan-Mamczarz, K., Kawai, T., Yang, X., Martindale, J. L., and Gorospe, M. (2004). Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J 23(15), 3092-102. Epub 2004 Jul. 15.
63. Lal, A., Kawai, T., Yang, X., Mazan-Mamczarz, K., and Gorospe, M. (2005). Antiapoptotic function of RNA-binding protein HuR effected through prothymosin alpha. EMBO J. 24, 1852-1862.
64. Li, P, Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., Wang, X. (1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489.
65. López de Silanes, I., Lal, A., Gorospe, M. (2005). HuR: post-transcriptional paths to malignancy. RNA Biol 2, 11-3.
66. Luo, J., Nikolaev, A. Y., Imai, S., Chen, D., Su, F., Shiloh, A., Guarente, L., and Gu, W. (2001). Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107, 137-148.
67. Marches, R., Hsueh, R., and Uhr, J. W. (1999). Cancer dormancy and cell signaling: Induction of p21waf1 initiated by membrane IgM engagement increases survival of B lymphoma cells. Proc Natl Acad Sci USA 96, 8711-8715.
68. Martin, A. G., and Fearnhead, H. O. (2002). Apocytochrome c blocks caspase-9 activation and Bax-induced apoptosis. J Biol Chem 277, 50834-50841.
69. Martin, A. G., Nguyen, J., Wells, J. A., Fearnhead, H. O. (2004). Apo cytochrome c inhibits cas-pases by preventing apoptosome formation. Biochem Biophys Res Commun. 319, 944-950.
70. Mazan-Mamczarz, K., Galban, S., López de Silanes, I., Martindale, J. L., Atasoy, U., Keene, J. D., and Gorospe, M. (2003). RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation. Proc Natl Acad Sci USA 100, 8354-8359.
71. Mazroui, R., Di Marco, S., Clair, E., von Roretz, C., Tenenbaum, S. A., Keene, J. D., Saleh, M., and Gallouzi, I. E. (2008). Caspase-mediated cleavage of HuR in the cytoplasm contributes to pp32/PHAPI regulation of apoptosis. J Cell Biol. 180, 113-127.
72. Meisner, N. C., Hintersteiner, M., Mueller, K., Bauer, R., Seifert, J. M., Naegeli, H. U., Ottl, J., Oberer, L., Guenat, C., Moss, S., Harrer, N., Woisetschlaeger, M., Buehler, C., Uhl, V., and Auer, M. (2007). Identification and mechanistic characterization of low-molecular-weight inhibitors for HuR. Nat Chem Biol 3, 508-515.
73. Mellert, H., Sykes, S. M., Murphy, M. E., McMahon, S. B. (2007). The ARF/oncogene pathway activates p53 acetylation within the DNA binding domain. Cell Cycle 6, 1304-1306.
74. Moore, M. J. (2005). From birth to death: the complex lives of eukaryotic mRNAs. Science 309, 1514-1518.
75. Motta, M. C., Divecha, N., Lemieux, M., Kamel, C., Chen, D., Gu, W., Bultsma, Y., McBurney, M., and Guarente, L. (2004). Mammalian SIRT1 represses forkhead transcription factors. Cell 116, 551-563.
76. Nagata, K., Kawase, H., Handa, H., Yano, K., Yamasaki, M., Ishimi, Y., Okuda, A., Kikuchi, A., and Matsumoto, K. (1995). Replication factor encoded by a putative oncogene, set, associated with myeloid leukemogenesis. Proc Natl Acad Sci USA 92, 4279-4283.
77. Orre, R. S., Cotter, II M. A., Subramanian, C., and Robertson, E. S. (2001). Prothymosin a functions as a cellular oncoprotein by inducing transformation of rodent fibroblasts in vitro. J Biol Chem 276, 1794-1799.
78. Pascale, A., Amadio, M., Quattrone, A. (2008). Defining a neuron: neuronal ELAV proteins. Cell Mol Life Sci 65, 128-140.
79. Pineiro, A., Cordero, O. J., and Nogueira, M. (2000). Fifteen years of prothymosin a: contradictory past and new horizons. Peptides 21, 1433-1446.
80. Pullmann, R. Jr., Kim, H. H., Abdelmohsen, K., Lal, A., Martindale, J. L., Yang, X., and Gorospe, M. (2007). Analysis of Stability and Translation Regulatory RBP Expression Through Binding to Cognate mRNAs. Mol Cell Biol 27, 6265-6278.
81. Rebane, A., Aab, A., and Steitz, J. A. (2004). Transportins 1 and 2 are redundant nuclear import factors for hnRNP A1 and HuR. RNA 10, 590-599.
82. Riedl, S. J. and Salvesen, G. S. (2007). The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 8, 405-413.
83. Rodriguez, J. and Lazebnik, Y. (1999). Caspase-9 and APAF-1 form an active holoenzyme. Genes Dev 13, 3179-3184.
84. Rodriguez, P., Vinuela, J. E., Alvarez-Fernandez, L., Buceta, M., Vidal, A., Dominguez, F., and Gomez-Marquez, J. (1998). Overexpression of prothymosin a accelerates proliferation and retards differentiation in HL-60 cells. Biochem J 331, 753-761.
85. Sburlati, A. R., Manrow, R. E, Berger, S. L. (1991). Prothymosin a antisense oligomers inhibit myeloma cell division. Proc Natl Acad Sci USA 88, 253-257
86. Schafer, Z. T., Kornbluth, S. (2006). The apoptosome: physiological, developmental, and pathological modes of regulation. Dev Cell 10, 549-561.
87. Schafer, Z. T., Parrish, A. B., Wright, K. M., Margolis, S. S., Marks, J. R., Deshmukh, M., and Kornbluth, S. (2006). Enhanced sensitivity to cytochrome c-induced apoptosis mediated by PHAPI in breast cancer cells. Cancer Res. 66, 2210-2218.
88. Semenza, G. L. (2003). Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3, 721-732.
89. Sengupta, S., Jang, B. C., Wu, M. T., Paik, J. H., Furneaux, H., Hla, T. (2003). The RNA-binding protein HuR regulates the expression of cyclooxygenase-2. J Biol Chem 278, 25227-25233.
90. Seo, S. B., McNamara, P., Heo, S., Turner, A., Lane, W. S., and Chakravarti, D. (2001). Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell 104, 119-130.
91. Sheflin, L. G., Zou, A. P., and Spaulding, S. W. (2004). Androgens regulate the binding of endogenous HuR to the AU-rich 3'UTRs of HIF-1a and EGF mRNA. Biochem Biophys Res Commun 322, 644-651.
92. Thompson, C. B. (1995). Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462.
93. van der Giessen, K., Di-Marco, S., Clair, E., Gallouzi, I. E. (2003). RNAi-mediated HuR depletion leads to the inhibition of muscle cell differentiation. J Biol Chem 278, 47119-47128.
94. Vaziri, H., Dessain, S. K., Ng Eaton, E., Imai, S. I., Frye, R. A., Pandita, T. K., Guarente, L., and Weinberg, R. A. (2001). hSIR2 (SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107, 149-159.
95. Vousden, K. H. and Lane, D. P. (2007) p53 in health and disease. Nat Rev Mol Cell Biol 8, 275-283.
96. Waldman, T., Lengauer, C., Kinzler, K. W., and Vogelstein, B. (1996). Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381, 713-716.
97. Wang, X., Gorospe, M., Huang, Y., and Holbrook, N. J. (1997). p27Kip1 overexpression causes apoptotic death of mammalian cells. Oncogene 15, 2991-2997.
98. Wang, W., Furneaux, H., Cheng, H., Caldwell, M. C., Hutter, D., Liu, Y., Holbrook, N., and Gorospe, M. (2000a). HuR regulates p21 mRNA stabilization by UV light. Mol Cell Biol 20, 760-769.
99. Wang, W., Caldwell, M. C., Lin, S., Furneaux, H., and Gorospe, M. (2000b). HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation. EMBO J 19, 2340-2350.
100. Wang, W., Yang, X., Kawai, T., López de Silanes, I., Mazan-Mamczarz, K., Chen, P., Chook, Y. M., Quensel, C., Köhler, M., and Gorospe, M. (2004). AMP-activated protein kinase-regulated phosphorylation and acetylation of importin a1: involvement in the nuclear import of RNA-binding protein HuR. J Biol Chem 279, 48376-48388.
101. Wenger, R. H., Stiehl, D. P. and Camenisch, G. (2005). Integration of oxygen signaling at the consensus HRE. Sci STKE 306: re12.
102. Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T.-I., Jones, D. P., and X. Wang. (1997). Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129-1132.
103. Zhao, J., Chen, J., Lu, B., Dong, L., Wang, H., Bi, C., Wu, G., Guo, H., Wu, M., and Guo, Y. (2008). TIP30 induces apoptosis under oxidative stress through stabilization of p53 messenger RNA in human hepatocellular carcinoma. Cancer Res 68, 4133-4141.
104. Zou, T., Mazan-Mamczarz, K., Rao, J. N., Liu, L., Marasa, B. S., Zhang, A. H., Xiao, L., Pullmann, R., Gorospe, M., and Wang, J. Y. (2006). Polyamine depletion increases cytoplas-mic levels of RNA-binding protein HuR leading to stabilization of nucleophosmin and p53 mRNAs. J Biol Chem 281, 19387-19394.